AOL Money & Finance

DF posts

Feed

Earnings highlights: CBS, Comcast, News Corp., Time Warner, UBS, Viacom ...

Here are some highlights from last week's earnings coverage from BloggingStocks:

Continue reading Earnings highlights: CBS, Comcast, News Corp., Time Warner, UBS, Viacom ...

Dean Foods (DF) issues weak Q4 guidance

DF logoDean Foods (NYSE: DF - option chain) stock traded lower Monday after the company reported Q3 earnings, posting an adjusted profit of 34 cents per share on revenue of $2.77 billion. While this beat analysts' expectations of 33 cents per share, the revenue targets were $2.94 billion. DF also forecast fourth-quarter EPS of 36 cents, missing analysts' projections of 39 cents. If you think this stock won't be rising too far in the coming months, then it could be a good time to look at a bearish hedged play on DF.

Monday, DF opened at $17.82. In early trading, the stock hit a high of $17.96 and a low of $16.43. As of 11:20, DF was trading at $16.59, down $1.64 (-9.0%). The chart for DF looks neutral and S&P gives DF a neutral 3 STARS (out of 5) hold ranking.

Continue reading Dean Foods (DF) issues weak Q4 guidance

Analyst upgrades, downgrades and initiations: AMZN, BA, BAC, F, LUV, LYG T, WEN ...

Analyst upgrades:

  • RBC Capital upgraded Bank of America (NYSE: BAC) to Outperform from Sector Perform and said the company has attractive franchise value and earnings power, and is nearing the start of a credit driven earnings recovery. The firm raised its target to $22 from $19.
  • Oppenheimer assumed coverage of Amazon.com (NASDAQ: AMZN) and upgraded shares to Outperform from Perform. The firm expects Amazon's revenue growth to re-accelerate over the next several quarters, making consensus estimates too conservative. Opco set a $130 price target on the stock.
  • Barclays upgraded Ford (NYSE: F) to Equal Weight from Underweight and believes the company will report Q3 results above the Street. The firm raised its Q3 EPS estimate to 7 cents from 16 cents, vs. consensus of 21 cents, and its price target to $8 from $7.
  • Charles River Labs (NYSE: CRL) was upgraded to Neutral from Sell at Goldman.
  • Briggs & Stratton (NYSE: BGG) was upgraded to Outperform from Neutral at Baird.
  • Sealed Air (NYSE: SEE) was upgraded to Equal Weight from Underweight at Barclays.

Continue reading Analyst upgrades, downgrades and initiations: AMZN, BA, BAC, F, LUV, LYG T, WEN ...

Analyst upgrades, downgrades and initiations: VIA, RIMM, ARO, JPM, BMY

Analyst upgrades:
  • Piper Jaffray upgraded Viacom (NYSE:VIA) to Overweight from Neutral to reflect the improving ad market and better ratings at key cable networks. The firm raised its target on shares to $35 from $29.
  • Baird upgraded Research in Motion (NASDAQ:RIMM) to Outperform from Neutral on valuation as it views the recent weakness as a buying opportunity. The firm keeps an $84 price target on shares.
  • Jefferies upgraded Usana (NASDAQ:USNA) to Buy from Hold as it believes direct selling companies have been gaining momentum. The firm raised its target on shares to $44 from $37.
  • AK Steel (NYSE:AKS) was upgraded to Buy from Hold at Deutsche Bank.
  • First Merit (NASDAQ:FMER) was upgraded to Perform from Underperform at Oppenheimer.
  • Spectra Energy (NYSE:SE) was upgraded to Conviction Buy from Neutral at Goldman.

Continue reading Analyst upgrades, downgrades and initiations: VIA, RIMM, ARO, JPM, BMY

Analyst upgrades, downgrades and initiations: ACI, CMCSA, DF, HPQ, LEAP, ZLC ...

Analyst upgrades:

  • FBR Capital upgraded CapitalSource (NYSE: CSE) to Outperform from Market Perform on valuation as it sees an attractive risk/reward at current levels. The firm raised its target on shares to $5 from $3.
  • Kaufman Bros. upgraded The Knot (NASDAQ: KNOT) to Buy from Hold following the company's Q2 results to reflect stable national advertising and a better bottom-line outlook. The firm raised its target on shares to $11 from $8.50.
  • Baird upgraded Obagi Medical (NASDAQ: OMPI) to Outperform from Neutral and raised its target to $10 from $7 following the strong Q2 report. The firm believes business bottomed in Q1 and the outlook is improving.
  • IPC The Hospitalist Co. (NASDAQ: IPCM) was upgraded to Overweight from Equal Weight at Stephens.
  • King Pharma (NYSE: KG) was upgraded at BofA/Merrill to Buy from Hold.
  • Infinera (NASDAQ: INFN) was upgraded to Hold from Underperform at Jefferies.

Continue reading Analyst upgrades, downgrades and initiations: ACI, CMCSA, DF, HPQ, LEAP, ZLC ...

The week in preview: Seeking more signs of economic stability

Last week's Fed Beige Book report and GDP numbers suggested that the economy may be stabilizing, and this coming week will bring plenty of economic data to confirm or deny that suggestion. On the schedule are consumer credit, construction spending, factory orders, and pending home sales for June, the employment situation, the Import Price Index, and new motor vehicle sales for July, as well as the ISM Manufacturing and Non-manufacturing Indexes for July.

The week will also bring quarterly reports from home builders Beazer Homes USA Inc. (NYSE: BZH), D.R. Horton Inc. (NYSE: DHI), and Pulte Homes Inc. (NYSE: PHM). Yet again, analysts surveyed by Thomson Reuters expect all three to have narrowed their losses in the most recent quarter. However, they've all tended to post deeper-than-expected losses in recent quarters as well. Analysts also expect to see their revenue down 45% or more for the past quarter. They forecast long-term EPS growth of 7% or more, but none of these homebuilders has a First Call consensus buy recommendation, not surprisingly. Short interest is falling off for Beazer and D.R. Horton, and D.R. Horton and Pulte have been reporting positive cash flow from operations, but all three of them said they had more long-term debt than cash in hand last time around. Mortgage insurer PMI Group Inc. (NYSE: PMI) is likewise expected to report that it narrowed its second-quarter loss.

Continue reading The week in preview: Seeking more signs of economic stability

Analyst upgrades, downgrades and initiations: LEN, RDC, FFIN, SII, AN, ACHN, UA, LULU, JST

Analyst upgrades:
  • Citigroup upgraded Lennar (NYSE: LEN) to Buy from Hold as it believes the company's near-term liquidity profile is improved following the $400M debt issuance. The firm raised its target price to $12 from $11.
  • Jefferies upgraded Rowan Companies (NYSE: RDC) to Buy from Hold as it believes jack-up drillers will continue to outperform deepwater names. The firm raised its target price to $27 from $20.
  • Keefe Bruyette upgraded First Financial (NASDAQ: FFIN) to Market Perform from Underperform to reflect more positive loan data for the Texas banks. The firm raised its target price on shares to $44 from $38.
  • MGM Mirage (NYSE: MGM) was upgraded to Overweight from Neutral at JP Morgan.
  • Morgan Stanley (NYSE: MS) was upgraded to Outperform from Market Perform at JMP Securities.
  • Brinker (NYSE: EAT) was upgraded to Overweight from Equal Weight at Barclays.

Continue reading Analyst upgrades, downgrades and initiations: LEN, RDC, FFIN, SII, AN, ACHN, UA, LULU, JST

Stocks in the news: MT, AMAT, NVDA, MJN, SIRI, CS, DF, NKE, RIMM, RTP ...

Before the bell: Stocks to rebound, but investors remain cautious

ArcelorMittal (NYSE: MT) swung to a surprising $2.6 billion loss in the fourth quarter -- its first ever -- as it experienced a collapse in demand and a sharp drop in prices. It wrote down $4.4 billion in pre-tax charges. The steel giant is also shedding some 9,000 workers. MT shares jumped over 6% in premarket trade.

Applied Materials (NASDAQ: AMAT) warned late Tuesday that chipmakers will spend 50% less this year for its products. The maker of semiconductor production equipment also posted a fiscal first-quarter loss of $3 million, excluding charges, and said it will cut 14% of its workforce, or about 2,000 jobs, as well as production. AMAT shares declined some 2% in premarket trade.

Continue reading Stocks in the news: MT, AMAT, NVDA, MJN, SIRI, CS, DF, NKE, RIMM, RTP ...

The week in preview: Coke versus Pepsi

It's about that time again: Pepsi vs. Coke. No, not another taste test or another Battle of the Brands. It's time for the next quarterly results from these two soft drink titans.

Analysts surveyed by Thomson Reuters anticipate that PepsiCo Inc. (NYSE: PEP), global beverage and snack food giant, will report fourth-quarter earnings this week that are 9.1% higher that a year ago, or $0.88 per share. Revenue is expected to total $12.8 billion, which is 3.9% higher than last year. For the full year, the profit is expected to be $3.67 per share on revenue of $43.4 billion, up from $3.38 per share on $39.5 billion in 2007. PepsiCo's earnings met or beat estimates in four of the past five quarters, but missed by only two cents per share in the third quarter. The consensus recommendation of analysts remains to buy PEP. The share price fell to a 52-week low in January and is now 24.4% lower than it was a year ago. During the fourth quarter, PepsiCo declared a $0.42 per share quarterly dividend, agreed to acquire a Spitz International, and announced investments in China and Mexico.

Continue reading The week in preview: Coke versus Pepsi

Earnings highlights: Ford, Toyota, Goldman Sachs, Disney, Sprint, ADM and others

Here are some highlights from this past week's earnings coverage from BloggingStocks:

Continue reading Earnings highlights: Ford, Toyota, Goldman Sachs, Disney, Sprint, ADM and others

Analyst calls: ETR, THO, AMN, DF, FOSL, NSRGY . . .

Analyst upgrades:
  • Baird expects Thor Industries (NYSE: THO) to benefit from industry consolidation and the eventual recovery. Shares were upgraded to Neutral from Underperform.
  • Jefferies upgraded SPSS Inc. (NASDAQ: SPSS) to Buy from Hold on valuation and believes the company's cost cuts will be positive for EPS. The company's target was lowered to $28 from $29.
  • Banc of America upgraded shares of Entergy (NYSE: ETR) to Buy from Neutral on valuation and believes the company is unlikely to spin-off Enexus by year-end. They believe a spin-off in 2009 or no spin at all suggests a higher share price from current levels. The company's target was raised to $104 from $101.50.
  • AMN Healthcare (NYSE: AMN) was upgraded to hold from Sell at Citigroup.
  • Argus upgraded Choice Hotels (NYSE: CHH) to Hold from Sell.
  • Transdigm Group (NYSE: TDG) was lifted to Buy from Neutral at UBS.

Analyst downgrades:

Continue reading Analyst calls: ETR, THO, AMN, DF, FOSL, NSRGY . . .

Before the bell: Stocks higher on Election Day; GE, MA, VIA, ADM, DF, MRVL, AAPL ...

U.S. stock futures were higher Tuesday morning at the start of the election day. Overseas, markets also edged higher ahead of the U.S. presidential election, while oil prices declined further to below $64 a barrel. While it is uncertain yet if any of the candidates would help boost sentiments and the markets as the economy is distressed either way, some analysts say much of the bad news around the economy and corporate profits are already priced into stocks. September factory orders will be released today.

General Electric Co. (NYSE: GE)'s arm GE Capital may be able to get some help from the Treasury. The Wall Street Journal reported its sources say the Treasury has been considering using more of its $700 billion rescue fund to buy stakes in a broad range of financial companies, not just banks and insurers. Apparently, initial signs show the program has been a success, and therefore might be expanded. CIT Group Inc. (NYSE: CIT) was cited as another candidate for help. GE shares are up 2.6% in premarket trading,

MasterCard Inc. (NYSE: MA) shares soared over 8% in after-hours trade Monday after the credit card processor has posted better-than-expected profit (after charges) boosted by revenue growth. It has also adjusted profit better than forecast. MasterCard, however, took a charge of $515 million for settling a lawsuit with Discover Financial Services (NYSE: DFS), making its net loss $194 million.

Viacom Inc. (NYSE: VIA) earnings, however, dropped 37% year over year, but adjusted earnings were inline with expectations.

Continue reading Before the bell: Stocks higher on Election Day; GE, MA, VIA, ADM, DF, MRVL, AAPL ...

Analyst calls: SCRX, GOOG, LOW, DF, GILD, EK, SOLR, XRX ...

Analyst upgrades:
  • RBC Capital upgraded Sciele Pharma (NASDAQ: SCRX) to Sector Perform from Underperform following the acquisition by Shionogi.
  • Merrill believes Alcoa (NYSE: AA) may pursue an acquisition of Alumina Ltd (NYSE: AWC) following recent share weakness. Shares of Alumina were upgraded to Buy from Underperform.
  • Stanford upgraded shares of Google (NASDAQ: GOOG) to Buy from Hold after channel checks indicated U.S. search market trends have stabilized as they believe GOOG's market share gains are broadening, Q3 expectations are modest and the valuation is near lows. The firm has a $550 target on the stock.
  • Lowe's (NYSE: LOW) was raised to Buy from Neutral at Goldman.
Analyst downgrades:
  • WestLB downgraded shares of Ericsson (NASDAQ: ERIC) to Reduce from Hold as they believe the company's Q3 earnings could miss expectations.
  • Lehman downgraded Intersil (NASDAQ: ISIL) to Equal Weight from Overweight based PC exposure and market share loss in notebook power. The company's target was lowered to $24 from $29.
  • Dean Foods (NYSE: DF) was lowered to Equal Weight from Overweight at Morgan Stanley.
  • Gilead Sciences (NASDAQ: GILD) was cut to Neutral from Buy at Banc of America.
  • JP Morgan lowered Bank of Nova Scotia (NYSE: BNS) to Underperform from Sector Perform.
Analyst initiations:
  • Citigroup initiated Eastman Kodak (NYSE: EK) with a Sell rating and $13 target. The firm believes 2008 consensus estimates and guidance are too high given the company's headwinds.
  • GT Solar (NASDAQ: SOLR) was assumed with a Neutral rating and $16 target at Banc of America. The firm believes the risk/reward is balanced at current levels with no significant new polysilicon opportunity. Shares were also initiated at Thomas Weisel with an Overweight rating and $18 target and at UBS with a Buy rating and $19 target.
  • Citigroup initiated Xerox (NYSE: XRX) with a Buy rating and $20 target and Electronics for Imaging (NASDAQ: EFII) with a Hold rating and $18 target.

Before the bell: Stocks to climb; LEH, GOOG, BA, AAPL, GM, LOW ...

U.S. stock futures were higher Tuesday morning as oil dropped $8 a barrel following little damage to oil rigs in the Gulf of Mexico from Gustav. Tuesday marks the return of many from the holiday weekend and the beginning of the school year. While oil will undoubtedly be the focus today, construction spending and ISM Index numbers are also due.

Korea Development Bank is in talks to buy a stake in Lehman Brothers Holdings Inc. (NYSE: LEH), Bloomberg reports. LEH shares are climbing over 5.5% in pre-market trading after CEO of the Korean bank confirmed the discussions. According to the Sunday Telegraph, KDB could inject as much as $6 billion of additional capital into Lehman. No doubt, this is something Fuld has been hoping for following the massive writedowns Lehman took. But is it something Americans wants as more foreign government-backed firms buy into Wall Street companies.

Meanwhile, the internet is abuzz over Google Inc. (NASDAQ: GOOG)'s introduction Tuesday of its own internet browser, Chrome, as it further butts heads with Microsoft Corp (NASDAQ: MSFT). While Microsoft has its Internet Explorer, other browsers exist, including the popular Mozilla's Firefox. Google claims its browser is designed better to show web applications and provide higher protection. GOOG shares are climbing over 1.5% in pre-market trading on the news.

Meanwhile, Alcatel-Lucent (NYSE: ALU) revamped its top management on Tuesday and named a former BT boss Ben Verwaayen as its new chief executive and Lagardere executive Philippe Camus as its new chairman. ALU shares are down about 1.5% in pre-market trading.

Continue reading Before the bell: Stocks to climb; LEH, GOOG, BA, AAPL, GM, LOW ...

Analyst upgrades: GENZ, DF, KEG, UFS, GOOD, M, REXMY

MOST NOTEWORTHY: Genzyme, Dean Foods and Key Energy Services were today's noteworthy upgrades:
  • Citigroup upgraded shares of Genzyme (NASDAQ: GENZ) to Buy from Hold as it sees EPS upside in 2008 and 2009 from the company's three upcoming product launches and improving operating margins. Citigroup raised its target to $91 from $80.
  • JP Morgan upgraded Dean Foods (NYSE: DF) to Overweight from Neutral citing valuation and expectations for dairy costs to decline.
  • Banc of America upgraded shares of Key Energy Services (NYSE: KEG) to Buy from Neutral to reflect the company's increasing pricing power and projected margin expansion for well services and growth opportunities in the shale plays. The firm raised its target price to $22 from $18.
OTHER UPGRADES:
  • Domtar (NYSE: UFS) was raised to Outperform from Sector Perform at RBC Capital.
  • Gladstone (NASDAQ: GOOD) was upgraded to Outperform from Neutral at Baird.
  • JP Morgan upgraded Macy's (NYSE: M) to Neutral from Underweight.
  • Goldman upgraded Rexam (OTC: REXMY) to Buy from Neutral.

Next Page >

Symbol Lookup
IndexesChangePrice
DJIA-17.2410,433.71
NASDAQ-6.832,169.18
S&P 500-0.591,105.65

Last updated: November 25, 2009: 04:15 AM

BloggingStocks Exclusives

Hot Stocks

DailyFinance Headlines

Latest from BloggingBuyouts

WalletPop Headlines

AOL Business News

BioHealth Investor Headlines

Sponsored Links

My Portfolios

Track your stocks here!

Find out why more people track their portfolios on AOL Money & Finance then anywhere else.

BloggingStocks Partners

More from AOL Money & Finance